# EDGAR Filing Document

**Accession Number:** 0002115494
**File Stem:** 0001683168-26-003462
**Filing Date:** 2026-5
**Character Count:** 11466
**Document Hash:** 05f7c9a8b6d0c489d14604ed2a03a8cd
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001683168-26-003462.hdr.sgml**: 20260504

**ACCESSION NUMBER**: 0001683168-26-003462

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260504

**DATE AS OF CHANGE**: 20260504

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Z Squared Inc.
- **CENTRAL INDEX KEY:** 0001759186
- **STANDARD INDUSTRIAL CLASSIFICATION:** FINANCE SERVICES [6199]
- **ORGANIZATION NAME:** 09 Crypto Assets
- **EIN:** 981465952
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-91807
- **FILM NUMBER:** 26939911

**BUSINESS ADDRESS:**
- **STREET 1:** 550 SOUTH ANDREWS AVE.
- **STREET 2:** STE #700
- **CITY:** FORT LAUDERDALE
- **STATE:** FL
- **ZIP:** 33301
- **BUSINESS PHONE:** 954-400-9994

**MAIL ADDRESS:**
- **STREET 1:** 550 SOUTH ANDREWS AVE.
- **STREET 2:** STE #700
- **CITY:** FORT LAUDERDALE
- **STATE:** FL
- **ZIP:** 33301

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Coeptis Therapeutics Holdings, Inc.
- **DATE OF NAME CHANGE:** 20221031

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Bull Horn Holdings Corp.
- **DATE OF NAME CHANGE:** 20181115
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BSG Series CM, LLC
- **CENTRAL INDEX KEY:** 0002115494

**ORGANIZATION NAME:**
- **EIN:** 922934344
- **STATE OF INCORPORATION:** SC
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D

**BUSINESS ADDRESS:**
- **STREET 1:** 211 N MAIN STREET
- **CITY:** GREENVILLE
- **STATE:** SC
- **ZIP:** 29601
- **BUSINESS PHONE:** 954-263-6102

**MAIL ADDRESS:**
- **STREET 1:** 211 N MAIN STREET
- **CITY:** GREENVILLE
- **STATE:** SC
- **ZIP:** 29601

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**Z Squared Inc.**

*(Name of Issuer)*

**Common Stock, par value $0.0001 per share**

*(Title of Class of Securities)*

**—**

*(CUSIP Number)*

**Steven Baldassarra**<br>211 N. Main Street<br>Greenville SC 29601<br>954-263-6102

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**04/24/2026**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**BSG Series CM, LLC** | Name of reporting person<br>**BSG Series CM, LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**SOUTH CAROLINA** | Citizenship or place of organization<br>**SOUTH CAROLINA** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**41521276.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**41521276.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**41521276.00** | Aggregate amount beneficially owned by each reporting person<br>**41521276.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**80.73%** | Percent of class represented by amount in Row (11)<br>**80.73%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock, par value $0.0001 per share

**(b) Name of Issuer:**
Z Squared Inc.

**(c) Address of Issuer's Principal Executive Offices:**
550 South Andrews Avenue, Suite 700, Fort Lauderdale, FL, 33301

**Item 4. Purpose of Transaction**

The Reporting Person acquired the Subject Shares as merger consideration in connection with the Merger as more fully described under Item 3 above.

The Reporting Person presently intends to distribute all or substantially all of the Subject Shares pro rata to its members in accordance with its operating agreement and applicable law (such distribution, the "Member Distribution"), at such time or times as the Reporting Person may determine. Any Member Distribution will be effected, and any subsequent disposition by transferees of any Subject Shares so distributed will be permitted, only in compliance with the lock-up and leak-out provisions described under Item 6 below and applicable federal and state securities laws. Following any Member Distribution, each member receiving Subject Shares will continue to be subject to the lock-up and leak-out provisions described under Item 6 below as a transferee thereof.

Except as set forth in this Item 4 and in Item 6 below, the Reporting Person has no present plans or proposals that relate to or would result in any of the actions enumerated in clauses (a) through (j) of Item 4 of Schedule 13D. The Reporting Person reserves the right at any time and from time to time, in light of its evaluation of various factors, to formulate other purposes, plans, or proposals regarding the Issuer or any of its securities, and to take any actions with respect to the Issuer or its securities (including any actions described in clauses (a) through (j) of Item 4 of Schedule 13D), in each case to the extent the Reporting Person deems advisable.

**Item 5. Interest in Securities of the Issuer**

**(a)**
The Reporting Person beneficially owns 41,521,276 shares of Common Stock, representing approximately 80.73% of the outstanding Common Stock. The percentage of beneficial ownership reported herein is based on 51,431,493 shares of Common Stock outstanding as of April 24, 2026, as represented by the Issuer to the Reporting Person. The Reporting Person has sole voting and sole dispositive power with respect to all 41,521,276 shares of Common Stock reported as beneficially owned by it. Information regarding the Reporting Person required by Item 2 of Schedule 13D is set forth in Item 2 above and is incorporated herein by reference.

**(b)**
See (a)

**(c)**
Other than the acquisition of the Subject Shares pursuant to the Merger as described under Item 3 above, the Reporting Person has not effected any transactions in the Common Stock during the 60 days preceding the date of this Statement.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

Asset-for-Share Exchange Agreement.

The Reporting Person is party to that certain Asset-for-Share Exchange Agreement with OpCo (as predecessor in interest to the Issuer) (the "Exchange Agreement"), pursuant to which the Reporting Person originally acquired the OpCo common stock that was subsequently exchanged in the Merger for the Subject Shares. The Exchange Agreement contains lock-up and leak-out provisions (collectively, the "Lock-Up and Leak-Out Provisions") that apply to the Reporting Person and to any transferee of any Subject Shares (including, without limitation, each member of the Reporting Person to whom Subject Shares may be distributed in any Member Distribution as described under Item 4 above).

The Lock-Up and Leak-Out Provisions provide, in summary, that:

(i) the Reporting Person may not sell, dispose of, or otherwise transfer any Subject Shares unless the volume-weighted average price of the Common Stock over the ten (10) consecutive trading days immediately preceding the proposed sale date exceeds $16.31 per share;

(ii) commencing on April 27, 2026 (the date the Common Stock began trading on the Nasdaq Global Market) and continuing for the eighteen (18) months thereafter, the Reporting Person and each transferee of Subject Shares (A) may not sell more than one-eighteenth (1/18) of the total number of Subject Shares beneficially owned by it in any calendar month, (B) may not engage in any short selling of the Common Stock, and (C) may not effect sales of Subject Shares that exceed five percent (5%) of the average daily trading volume of the Common Stock over the ten (10) trading days immediately preceding such sale; and

(iii) notwithstanding clauses (i) and (ii) above, the Reporting Person and each transferee of Subject Shares may sell Subject Shares if the publicly quoted closing price of the Common Stock exceeds $35.00 per share for any two (2) consecutive trading days.

 The foregoing description of the Lock-Up and Leak-Out Provisions is qualified in its entirety by reference to the Exchange Agreement, a copy of which is filed as Exhibit 99.1 hereto and is incorporated herein by reference.

Merger Agreement.

The terms of the Merger and the conversion of the Reporting Person's pre-Merger OpCo common stock into the Subject Shares are governed by the Merger Agreement, as amended by the Limited Waiver and First Amendment to Merger Agreement, dated May 27, 2025 (the "First Amendment"), the Limited Waiver and Second Amendment to Merger Agreement, dated June 10, 2025 (the "Second Amendment"), the Limited Waiver and Third Amendment to Merger Agreement, dated June 20, 2025 (the "Third Amendment"), the Limited Waiver and Fourth Amendment to Merger Agreement, dated August 17, 2025 (the "Fourth Amendment"), the Limited Waiver and Fifth Amendment to Merger Agreement, dated September 10, 2025 (the "Fifth Amendment"), and the Limited Waiver and Sixth Amendment to Merger Agreement, dated September 30, 2025 (the "Sixth Amendment," and together with the First Amendment through the Fifth Amendment, the "Amendments"). The Merger Agreement and each of the Amendments are incorporated herein by reference to Exhibits 99.2 through 99.8 hereto.

Except as set forth in this Statement, the Reporting Person is not party to any contract, arrangement, understanding, or relationship (legal or otherwise) with any person with respect to any securities of the Issuer, including but not limited to transfer or voting of any of the securities, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies. None of the Subject Shares are pledged or otherwise subject to a contingency the occurrence of which would give another person voting power or investment power over the Subject Shares.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** BSG Series CM, LLC

**Signature:** /s/ Steven Baldassarra

**Name/Title:** Steven Baldassarra, Chief Executive Officer

**Date:** 05/04/2026